Palvella Therapeutics (PVLA) EPS (Basic) Growth (3y) (2016 - 2026)
Palvella Therapeutics (PVLA) EPS (Basic) Growth (3y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Basic) Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
-27.25% |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
139.68% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
25.99% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
85.94% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
41.58% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
14.28% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Palvella Therapeutics |
1.49 Bn |
1.23 Bn |
- |
56.07% |
| Date | Value |
|---|
| Mar 31, 2026 |
56.07% |
| Sep 30, 2025 |
-99.36% |
| Jun 30, 2025 |
-83.14% |
| Mar 31, 2025 |
-119.47% |
| Dec 31, 2024 |
42.98% |
| Sep 30, 2024 |
-154.15% |
| Jun 30, 2024 |
-114.58% |
| Mar 31, 2024 |
-180.20% |
| Dec 31, 2023 |
332.54% |
| Sep 30, 2023 |
-222.24% |
| Jun 30, 2023 |
248.52% |
| Mar 31, 2023 |
-486.88% |
| Sep 30, 2022 |
-37.51% |
| Jun 30, 2022 |
16.45% |
| Mar 31, 2022 |
29.53% |
| Dec 31, 2021 |
14.77% |
| Sep 30, 2021 |
-29.70% |
| Jun 30, 2021 |
-305.10% |
| Mar 31, 2021 |
25.60% |
| Dec 31, 2020 |
-51.02% |
